We now have many choices of oral agents in the treatment of type 2 diabetes patients. But choosing the type and where they fit in the treatment algorithm can be a challenge. Join host Dr. Steven Edelman and his guest, director of the Harold Schnitzer Diabetes Health Center, Dr. Andrew Ahmann, as they discuss the different classes of oral agents, benefits and treatment algorithms in the treatment of type 2 diabetes.
Oral Agents for Diabetes: What to Choose and When
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
We now have many choices of oral agents in the treatment of type 2 diabetes patients. But choosing the type and where they fit in the treatment algorithm can be a challenge. Join host Dr. Steven Edelman and his guest, director of the Harold Schnitzer Diabetes Health Center, Dr. Andrew Ahmann, as they discuss the different classes of oral agents, benefits and treatment algorithms in the treatment of type 2 diabetes.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Updates From the 7th World Symposium Task Force
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
Pulmonary Hypertension Management: Practice Trends and Updates
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
Evaluating Sleep Deprivation as a Risk Factor for Postpartum Depression
mIDH Gliomas Explained: Characteristics and Management Strategies
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?